BackRapport Therapeutics Overview

Rapport Therapeutics Common Stock

Track Rapport Therapeutics's common stock ($48K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$48000.00
↑ 29.73% YoYΔ $11000.00 vs prior year quarter

Peer average

Loading

Rapport Therapeutics Common Stock History

Loading

Rapport Therapeutics vs. peers: Common Stock Comparison

Loading

Rapport Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Rapport Therapeutics (RAPP) FAQ

As of the most recent data (March 2026), RAPP shows a common stock of $48K. That compares with $37K in the prior-year period — up 29.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RAPP's common stock is now $48K (was $37K) — a 29.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rapport Therapeutics is outperforming or lagging.

Tracking RAPP's common stock over time shows whether Rapport Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $48K That compares with $37K in the prior-year period — up 29.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Rapport Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $48K) with ownership activity and broader fundamentals.